Merck & Co., Inc. (MRK) NYSE
111.72
+1.49(+1.35%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
111.72
+1.49(+1.35%)
Currency In USD
| Market Cap | 263.93B |
| Enterprise Value | 299.9B |
| P/E Ratio | 15.24 |
| PEG Ratio | 1.91 |
| Price/Sales Ratio | 4.25 |
| Price/Book Ratio | 5.29 |
| Enterprise/Revenue | 4.8 |
| Enterprise/EBITDA | 11.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.28 |
| Operating Margin | 0.41 |
| Return On Assets | 0.13 |
| Return On Equity | 0.36 |
| Revenue | 65.01B |
| Revenue/Share | 26.11 |
| Gross Profit | 52.98B |
| EBITDA | 25.36B |
| Net Income | 18.25B |
| Diluted EPS | 7.28 |
| Total Cash | 14.57B |
| Total Cash/Share | 5.85 |
| Total Debt | 50.53B |
| Total Debt/Equity | 0.96 |
| Current Ratio | 1.54 |
| Book Value Per Share | 21.15 |
| 52-Week Change | 34.29 |
| 52-Week High | 125.14 |
| 52-Week Low | 73.31 |
| Moving Average 50 Days | 118.42 |
| Moving Average 200 Days | 99.34 |
| Average Volume | 11.15M |
| Shares Outstanding | 2.47B |
| % Held by Institutions | 78.97 |
| Trailing Annual Dividend Rate | 3.32 |
| Trailing Annual Dividend Yield | 2.97 |
| Payout Ratio | 0.45 |
| Last Split Factor | 131:125 |
| Last Split Date | June 03, 2021 |